COMMUNIQUÉS West-GlobeNewswire
-
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
02/07/2026 -
GuideAI Health Corp. Engages Market Maker
02/07/2026 -
Monthly information on share capital and company voting rights
02/07/2026 -
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
02/07/2026 -
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
02/07/2026 -
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026
02/07/2026 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
02/07/2026 -
GENFIT annonce l’accès à la couverture et le futur remboursement par Medicare aux États-Unis de NASHnext®, une technologie visant à identifier les patients atteints de MASH « à risque »
02/07/2026 -
Profusa Announces 1-for-25 Reverse Stock Split
02/07/2026 -
Déclaration droits de vote - 30 juin 2026
02/07/2026 -
CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative
02/07/2026 -
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
02/07/2026 -
Declaration voting rights - June 30,2026
02/07/2026 -
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
02/07/2026 -
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
02/07/2026 -
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology
02/07/2026
Pages